Doxazosin
| CAS No. | 74191-85-8 |
|---|---|
| MDL No. | MFCD00800482 |
| MF | C23H25N5O5 |
| MW | 451.50 |
| InChI Key | RUZYUOTYCVRMRZ-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Doxazosin is a quinazoline derivative substituted with an amino group at position 4, methoxy groups at positions 6 and 7, and a piperazin-1-yl group at position 2, which is further substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. It is an antihypertensive agent used in the treatment of high blood pressure. It functions as an alpha-adrenergic antagonist, vasodilator, antihyperplasia drug, and has antineoplastic properties. It belongs to the classes of quinazolines, N-acylpiperazines, N-arylpiperazines, benzodioxines, monocarboxylic acid amides, and aromatic amines.
| CAS No. | 74191-85-8 |
|---|---|
| Product Name | Doxazosin |
Biological Targets
ADRA1A·ADRA1D·ADRA1B
Associated Conditions
Paraganglioma·hypertension·benign prostatic hyperplasia·cocaine dependence·Hypercholesterolemia·
* The information provided here is compiled from public sources and is for reference only.
